Indiana Pharma Research Company Files Chapter 11 in Houston
The analytical drug discovery and development services and research company Inotiv and 18 of its affiliated entities filed for Chapter 11 bankruptcy protection Wednesday in the Southern District of Texas.
Inotiv, which cites $500 million to $1 billion in both liabilities and assets, hired Ropes & Gray and Hunton Andrews Kurth as its lead legal advisors.
